SCHEMBL24187366

SCHEMBL24187366

CCOC(=O)c1cc2sccc2n1CCNC(=O)OC(C)(C)C

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.60
TSHR P16473 12/20 0.59
POLB P06746 3/20 0.59
HSD17B10 Q99714 3/20 0.59
ALDH1A1 P00352 5/20 0.56
MAPT P10636 5/20 0.56
ATM Q13315 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
NPSR1 Q6W5P4 3/20 0.55
HTT P42858 1/20 0.55
LMNA P02545 3/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
HPGD P15428 2/20 0.50
USP2 O75604 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
MITF O75030 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.47
RAB9A P51151 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20141699 0.81 MTNR1A (0.59) KDM4ETSHRALDH1A1MAPTHTT
SCHEMBL16150685 0.80 MAPT (0.47) KDM4EHSD17B10ALDH1A1MAPTNPSR1
SCHEMBL7960876 0.79 F10 (0.50) KDM4ETSHRHSD17B10ALDH1A1MAPT
SCHEMBL24187363 0.79 TSHR (0.71) KDM4ETSHRPOLBHSD17B10ALDH1A1
SCHEMBL24187458 0.78 MTNR1A (0.46) KDM4EMAPTTDP1NPSR1SMN1; SMN2
SCHEMBL15563812 0.78 DRD2 (0.44) KDM4ETSHRHSD17B10ALDH1A1MAPT
SCHEMBL17554396 0.78 TSHR (0.78) KDM4ETSHRPOLBHSD17B10ALDH1A1
SCHEMBL16151412 0.78 GAA (0.43) KDM4EPOLBALDH1A1MAPTTDP1
SCHEMBL27141102 0.77 DRD2 (0.39) KDM4ETSHRALDH1A1MAPTTDP1
SCHEMBL29153650 0.77 MTNR1A (0.42) KDM4EALDH1A1MAPTHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022007866-A1 FUSED TRICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL APPLICATION THEREOF 深圳信立泰药业股份有限公司 2022-01-13 WO disclosed